Left ventricular diastolic function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 4, 2012, Pages 804-811

  Korosoglou, Grigorios ^a   Humpert, Per M ^a   Ahrens, Johannes ^a   Oikonomou, Dimitrios ^a   Osman, Nael F ^b,c   Gitsioudis, Gitsios ^a   Buss, Sebastian J ^a   Steen, Henning ^a   Schnackenburg, Bernhardt ^d   Bierhaus, Angelika ^a   Nawroth, Peter P ^a   Katus, Hugo A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NILE UNIVERSITY   (Egypt)

^d PHILIPS HEALTHCARE   (United States)

Author keywords

diastolic function; myocardial triglyceride content; strain encoded MRI; type 2 diabetes mellitus; vascular function

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DIABETIC CARDIOMYOPATHY; DIASTOLE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HUMAN; HYPEREMIA; MALE; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRIACYLGLYCEROL BLOOD LEVEL;

CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84858726310     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22879     Document Type: Article

References (27)

1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM,. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
2. Boyer JK, Thanigaraj S, Schechtman KB, Perez JE,. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004; 93: 870-875.
3. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ,. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202.
4. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA,. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 2001; 87: 320-323.
5. de Simone G, Devereux RB, Chinali M, et al. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens 2010; 28: 353-360.
6. Wild S, Roglic G, Green A, Sicree R, King H,. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
7. Korosoglou G, Lehrke S, Wochele A, et al. Strain-encoded CMR for the detection of inducible ischemia during intermediate stress. JACC Cardiovasc Imaging 2010; 3: 361-371.
8. Korosoglou G, Lossnitzer D, Schellberg D, et al. Strain-encoded cardiac MRI as an adjunct for dobutamine stress testing: incremental value to conventional wall motion analysis. Circ Cardiovasc Imaging 2009; 2: 132-140.
9. Korosoglou G, Osman NF, Dengler TJ, et al. Strain-encoded cardiac magnetic resonance for the evaluation of chronic allograft vasculopathy in transplant recipients. Am J Transplant 2009; 9: 2587-2596.
10. Korosoglou G, Riedle N, Erbacher M, et al. Quantitative myocardial blush grade for the detection of cardiac allograft vasculopathy. Am Heart J; 159: 643-651 e642.
11. McGavock JM, Lingvay I, Zib I, et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007; 116: 1170-1175.
12. Rijzewijk LJ, van der Meer RW, Smit JW, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008; 52: 1793-1799.
13. van der Meer RW, Doornbos J, Kozerke S, et al. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 2007; 245: 251-257.
14. Korosoglou G, Youssef AA, Bilchick KC, et al. Real-time fast strain-encoded magnetic resonance imaging to evaluate regional myocardial function at 3.0 Tesla: comparison to conventional tagging. J Magn Reson Imaging 2008; 27: 1012-1018.
15. Ennis DB, Epstein FH, Kellman P, Fananapazir L, McVeigh ER, Arai AE,. Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging. Magn Reson Med 2003; 50: 638-642.
16. Korosoglou G, Elhmidi Y, Steen H, et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol 2010; 56: 1225-1234.
17. Korosoglou G, Humpert PM,. Non-invasive diagnostic imaging techniques as a window into the diabetic heart: a review of experimental and clinical data. Exp Clin Endocrinol Diabetes 2007; 115: 211-220.
18. Fang ZY, Prins JB, Marwick TH,. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 25: 543-567.
19. Poulsen MK, Henriksen JE, Dahl J, et al. Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging 2010; 3: 24-31.
20. Moir S, Hanekom L, Fang ZY, et al. Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging. Heart 2006; 92: 1414-1419.
21. Shivu GN, Phan TT, Abozguia K, et al. Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus. Circulation 2010; 121: 1209-1215.
22. Ng AC, Delgado V, Bertini M, et al. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation 2010; 122: 2538-2544.
23. Rijzewijk LJ, Jonker JT, van der Meer RW, et al. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J Am Coll Cardiol 2010; 56: 225-233.
24. Boudina S, Abel ED,. Diabetic cardiomyopathy revisited. Circulation 2007; 115: 3213-3223.
25. Boudina S, Abel ED,. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 2010; 11: 31-39.
26. Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 2000; 97: 1784-1789.
27. King H, Aubert RE, Herman WH,. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.